tradmap

ISPC iSpecimen Inc.

$1.56 +4.70%

Updated

Industrials · Services-Commercial Physical & Biological Research

iSpecimen Inc. (ISPC) is a industrials company in the Services-Commercial Physical & Biological Research industry, with a market capitalization of $4 million. Shares last traded at $1.56, 99.0% below their 52-week high. Over the past year the stock is down 94.3%. Net profit margin is -592.0%, below the peer median of 8.3%. Revenue declined 79.2% year over year.

Market Cap
$4M
Shares Out
2.5M
EPS (TTM)
$-57.28
P/E Ratio
P/S Ratio
2.04
P/B Ratio
2.26
Dividend / Share
Dividend Yield
52-Week High
$149.65
52-Week Low
$1.41
Volume
878
Avg Vol (3m)
5,606.222

Performance

1W
-1.27%
1M
-22.00%
3M
-51.10%
6M
-84.35%
YTD
-86.83%
1Y
-94.30%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. ISPC split history →

Technicals

RSI (14)
36.44
SMA (50)
$2.13
SMA (200)
$8.13
Price vs SMA50
-26.76%
Price vs SMA200
-80.80%
ATR (14)
$0.19

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2M
Net Income
$-11M
Gross Margin
-26.2%
Operating Margin
-488.3%
Net Margin
-592.0%
Return on Equity
-657.7%
Return on Assets
-154.5%
Current Ratio
0.82
Debt / Equity
1.98
Revenue Growth (YoY)
-79.2%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-4.18 2026-08-14
Q1 2026 $-6.66 2026-05-18
FY 2025 $-2.28 2026-04-01
Q3 2025 $-1.54 2025-11-17
Q2 2026 $-44.90 2026-08-14
Q1 2026 $-28.55 2026-05-18

Full earnings history →

Services-Commercial Physical & Biological Research peers

ISPC vs 14 industry peers (Services-Commercial Physical & Biological Research), by market cap. Updated

P/S vs peers
2.04 / 4.14 med
-51% discount
Net margin vs peers
-592.0% / 8.3% med
below median
1–14 of 14
IQVIQVIA$45.3B32.742.738.3%+2.95%
INCYIncyte$25.6B17.864.7726.7%-0.68%
MEDPMedpace Holdings, Inc.$16.6B33.705.9517.7%+0.09%
CRLCharles River Laboratories$14.0B-58.723.50-6.0%+0.54%
ABSIAbsci Corp$1.5B-12.46332.71-0.06%
OABIOmniAb, Inc.$689M-15.57-5.77%
NRCNrc Health$470M40.513.368.3%+6.23%
MXCTMAXCYTE, INC.$131M-3.66-1.17%
BIAFbioAffinity Technologies, Inc.$100M-6.60+22.48%
ONMDOneMedNet Corp$35M-4.15+4.13%
ISPCiSpecimen Inc.$4M-0.34+4.70%
IBACRIB Acquisition Corp.$580955-1.45+0.87%
ICLRIcon Plc2.1%+2.36%
BIAFWbioAffinity Technologies, Inc.+80.18%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.